Home > Insider Trading > Filing (0001209191-19-029147)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337334	Steven Shak	301 Penobscot Drive Redwood City CA 94063	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-05-08	3,100	$56.97	255,379	No	4	S	Indirect	Held by the Shak Family Trust
Common Stock	Disposition	2019-05-08	15,300	$57.68	240,079	No	4	S	Indirect	Held by the Shak Family Trust
Common Stock	Disposition	2019-05-08	6,500	$58.84	233,579	No	4	S	Indirect	Held by the Shak Family Trust
Common Stock	Disposition	2019-05-08	100	$59.59	233,479	No	4	S	Indirect	Held by the Shak Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by the Shak Family Trust
No	4	S	Indirect	Held by the Shak Family Trust
No	4	S	Indirect	Held by the Shak Family Trust
No	4	S	Indirect	Held by the Shak Family Trust

Footnotes

These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $56.44 to $57.40.
Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Represents weighted average sale price. Actual sale prices ranged from $57.45 to $58.44.
Represents weighted average sale price. Actual sale prices ranged from $58.455 to $59.43.
Represents actual sale price.